SOURCE: TalkPoint

TalkPoint

March 01, 2011 09:16 ET

FDAAdvisoryCommittee.com to Webcast Discussions on Drug Development for Orphan and Rare Diseases

Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee Will Be Streamed Live and Archived for Six Months

NEW YORK, NY--(Marketwire - March 1, 2011) - FDAAdvisoryCommittee.com (FDAAC.com), a provider of live video webcasts of Food and Drug Administration (FDA) Advisory Committee meetings, today announced that it will webcast the Pharmaceutical Science and Clinical Pharmacology Advisory Committee's discussions on innovative approaches to the development of drugs for orphan and rare diseases to support decisions such as dose and trial design selection. The meeting will be held on March 2, 2011 from 7:15 a.m. CT to 3:00 p.m. CT. 

The Pharmaceutical Science and Clinical Pharmacology Advisory Committee will provide suggestions to the FDA on how to optimally utilize mechanistic biomarkers and apply clinical pharmacology tools, such as pharmacogenetics and modeling and simulation, to facilitate efficient and informative drug development and regulatory review. The FDA will present and seek input from the Committee on how lessons learned from other applications of clinical pharmacology tools in pediatrics and oncology can be applied to orphan and rare diseases.

Audience members, including pharmacologists, and journalists, will be able to watch from anywhere in the world as the Pharmaceutical Science and Clinical Pharmacology Advisory Committee comments on the current status and future direction for clinical pharmacology studies as they pertain to drug development for orphan and rare diseases. FDAAC.com will webcast the meeting live and on location from the Hyatt Regency Dallas.

FDAAC.com is committed to delivering the highest quality of video and experience. By utilizing h.264 encoding in conjunction with Flash Media, FDAAC.com's webcasts deliver a near instantaneous stream. These high-quality streams can be accessed from anywhere around the globe and are archived for six months after the live event for unlimited review.

FDAAC.com's webcasts are powered by TalkPoint, a provider of Web-based audio and video Webcasting solutions and services. With over a decade of experience, TalkPoint has developed the most robust, scalable, interactive webcasting platform in the industry. TalkPoint's easy-to-use applications incorporate audio, video, slides, and other interactive elements to deliver high-impact webcasts cost-effectively.

To join the webcast on March 1 at 7:15 a.m. CT register at http://fdaac.com

About FDAAdvisoryCommittee.com
FDAAC.com provides live video webcasts of FDA Advisory Committee meetings captured on location. These meetings cover an array of topics related to medicinal health including OTC, prescription and treatment devices. Very often meetings will result in rulings on clinical trials, final approval and bans of medications and treatment options. TalkPoint is the exclusive webcast provider for FDAAdvisoryCommitte.com.

For more information on FDAAC.com, go to www.fdaac.com.

Contact Information

  • Media Contacts:
    Richard Taber
    FDAAdvisoryCommittee.com
    Tel: (800) 627-8171
    Email Contact

    Susan Kiddy
    LVA Communications
    Tel: (860) 739-5598
    Email: Email Contact